Skip to main content

FISICA NUCLEAR Y APLICACIONES MEDICAS EN EL CNA E INSTALACIONES INTERNACIONALES

FPA2016-77689-C2-1-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Proton RBE at low energies: preparation of a new radiobiology beam line at the 18 MeV proton cyclotron facility at CNA

  • Baratto-Roldan, Anna
  • Cortés-Giraldo, Miguel Antonio
  • Jiménez-Ramos, M. C.
  • Battaglia, M. C.
  • García López, J.
  • Gallardo, María Isabel
  • Espino, J. M.
Trabajo presentado en las II Jornadas RSEF / IFIMED de Física Médica, celebradas en Madrid (España), del 14 al 15 de junio de 2018, In the last decades, proton therapy has gained great interest in the medical community thanks to its excellent clinical results. The bases of this success are: (1) the physical advantages of protons with respect to conventional radiation therapy with photons, due to their more selective energy deposition in depth; and (2) their increased radiobiological effectiveness as compared with photon radiotherapy for a same level of absorbed dose, property usually referred to as Relative Biological Effectiveness or RBE. Even if it is agreed that proton RBE varies towards the distal Bragg peak region, increasing with LET, nowadays in clinical proton therapy treatments, a uniform RBE value of 1.1 is generally used. Therefore, studies of RBE at low proton energies are necessary in order to reach a consensus on the RBE variations near the Bragg peak, which could be significant in the optimization of proton therapy treatment plans. With the purpose of providing a monochromatic beam for RBE measurements at low energies (below 18 MeV in our case), we are preparing an experimental setup at the external beam line of the 18MeV proton cyclotron facility installed at the CNA (Seville, Spain). In this work, we present our first feasibility studies. Two are the main constraints when dealing with the irradiation of biological samples in our setup: low beam intensity, of the order of some pA, to control properly the fluence during irradiation time, and broad irradiation field, of the order of 3cm side, uniform in both energy and space. To improve the homogeneity and decrease the beam intensity, we have decided to use a completely defocused beam and to scatter the beam downstream the exit window, both placing tungsten foils of different thicknesses and changing the amount of air between the window and the position of the samples. So far, we have measured the properties of wide beams produced with tungsten scattering foils of various thicknesses. With a 150 m thick tungsten foil, we could produce a 10 MeV proton beam with almost homogeneous intensity, having deviations of the order of ~10% in the central 35 mm and at ~50 cm distance from the exit window. Furthermore, we have performed preliminary dosimetric studies, using EBT3 radiochromic films and a transmission ionization chamber for dose and proton fluence evaluation. Studies of this nature are of great interest, since radiochromic films would be a handy and easy to use dosimeter solution for proton RBE studies. Finally, we are developing with the Geant4 toolkit a Monte Carlo tool, which reproduces accurately the cyclotron beam properties with the aim of simulating future improvements proposed on the final optimization of the setup for the irradiation of biological samples., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675265, OMA - Optimization of Medical Accelerators, and from the Spanish Ministry of Economy and Competitiveness under grant No FPA2016-77689-C2-1-R. The Monte Carlo simulations were carried out at the FIS-ATOM cluster hosted at CICA (Seville, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Development of a new radiobiology beam line for the study of proton RBE at the 18 MeV proton cyclotron facility at CNA

  • Baratto-Roldan, Anna
  • Cortés-Giraldo, Miguel Antonio
  • Jiménez-Ramos, M. C.
  • García López, J.
  • Gallardo, María Isabel
  • Espino, J. M.
Trabajo presentado en Rábida 2018: International Scientific Meeting on Nuclear Physics, celebrado en La Rábida (Sevilla, España), del 18 al 22 de junio de 2018, In the last decades, particle radiation therapy, mainly performed with protons and carbon ions, has gained great interest in the medical community thanks to its excellent clinical results. The bases of this success are: (1) the physical advantages of protons and heavier ions with respect to conventional radiation therapy with photons, due to their more selective energy deposition in depth; and (2) their increased radiobiological effectiveness, since protons and heavier ions offer a higher cell-killing effectiveness if compared to photons for a same level of absorbed dose, property usually referred to as Relative Biological Effectiveness or RBE. The RBE depends on different factors, both physical and biological, such as radiation quality, track structure, linear energy transfer (LET), tissue type, biological endpoint, etc. However, in the case of protons, there is still place for improvements in what concerns the understanding of the behaviour of the RBE on both cancer and healthy cells, and its role in treatment planning and delivery. Even if it is agreed that proton RBE varies towards the distal Bragg peak region, increasing with LET, nowadays in clinical proton therapy treatments, a uniform RBE value of 1.1 is generally used, leading possibly to suboptimal proton treatment plans, as stated in Wedenberg et al. Therefore, studies of RBE at low proton energies are necessary in order to optimize proton therapy treatment plans and reach a consensus on the RBE variations near the Bragg peak. However, not many proton facilities can provide a monochromatic beam for radiobiological measurements at low energies (roughly below 20 MeV). With this purpose, we are preparing an experimental setup at the external beam line of the 18MeV proton cyclotron facility installed at the CNA (Seville, Spain) to cover this gap. [Methods and Results] In this work, we present our first feasibility studies. At present, the experimental beam line installed at the cyclotron facility counts on two Faraday cups for beam diagnostics, and on two collimators of 1.5 cm diameter placed at 1 m distance one from the other, the second of them mounted together with a 100 µm Aluminium exit window, for beam delivery and shaping. Two are the main constraints when dealing with cell irradiations: low beam intensity, of the order of some pA, to control properly the fluence during irradiation time, and broad irradiation field, of the order of 3cm side, uniform in both energy and space. In order to improve the homogeneity and decrease the beam intensity, we have decided to use a completely defocused beam and to scatter the beam downstream the exit window, both placing tungsten foils of different thicknesses and changing the amount of air between the window and the samples position. So far, we have measured the properties of wide beams produced with tungsten scattering foils of various thicknesses. With a 150 m thick tungsten foil, we could produce a 10 MeV proton beam with almost homogeneous intensity, having deviations of the order of ~10% in the central 35 mm and at ~50 cm distance from the exit window. Furthermore, we have performed preliminary dosimetric studies, using EBT3 radiochromic films and a transmission ionization chamber for dose and proton fluence evaluation. Studies of this nature are of great interest, since radiochromic films would be a handy and easy to use dosimeter solution for proton RBE studies. Finally, we are developing with the Geant4 toolkit a Monte Carlo tool, which reproduces accurately the cyclotron beam properties with the aim of simulating future improvements proposed on the final optimization of the setup for the irradiation of biological samples., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675265, OMA Optimization of Medical Accelerators, and from the Spanish Ministry of Economy and Competitiveness under grand No FPA2016-77689-C2-1-R. The Monte Carlo simulations were carried out at the FIS-ATOM cluster hosted at CICA (Seville, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Microdosimetry-based dose-averaged linear energy transfer calculation for clinical proton beams: a Monte Carlo study with Geant4-DNA

  • Baratto-Roldan, Anna
  • Perales, C.
  • Bertolet, A.
  • Kimstrand, P.
  • Carabe, Alejandro
  • Cortés-Giraldo, Miguel Antonio
Trabajo presentado en el 3rd Geant4 International User Conference at the Physics, Medicine, Biology frontier, celebrado en Bordeaux (Francia), del 29 al 31 de octubre de 2018, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675265, OMA – Optimization of Medical Accelerators, and from the Spanish Ministry of Economy and Competitiveness under grant No FPA2016- 77689-C2-1-R. The Monte Carlo simulations were carried out at the FIS-ATOM cluster hosted at CICA (Seville, Spain)., Peer reviewed